HIV Type 1 Genetic Diversity and Naturally Occurring Polymorphisms in HIV Type 1 Kenyan Isolates: Implications for Integrase Inhibitors
- 1 August 2012
- journal article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 28 (8) , 933-936
Abstract
Little is known about the extent and predictors of polymorphisms potentially influencing susceptibility to HIV integrase inhibitors. HIV-1 genetic diversity and drug resistance are major challenges in patient management globally. To evaluate HIV genetic diversity and drug resistance-associated mutations within a Nairobi cohort, genetic analysis of the HIV-1 pol-integrase gene regions was performed on samples collected from 42 subjects and 113 Kenyan intergrase sequences deposited in the Los Alamos HIV database. From the partial pol - integrase sequences analyzed phylogenetically, it was shown that 26 (61.9%) were subtype A1, 9 (21.4%) were subtype D, 5 (11.9%) were subtype C, 1 (2.4%) was subtype A2 and 1 (2.4%) was subtype CRF. Integrase-associated mutations were found in 12 patients, and in all 113 sequences already deposited in GenBank. One sample from this study and five from previous Kenyan integrase sequences had mutations at T97A, which is associated with reduced susceptibility to raltegravir.Keywords
This publication has 10 references indexed in Scilit:
- Increased Genetic Diversity of HIV-1 Circulating in Hong KongPLOS ONE, 2010
- Genetic Diversity on the Integrase Region of the pol Gene among HIV Type 1-Infected Patients Naive for Integrase Inhibitors in São Paulo City, BrazilAIDS Research and Human Retroviruses, 2010
- HIV Type 1 Subtype Diversity and Drug Resistance among HIV Type 1-Infected Kenyan Patients Initiating Antiretroviral TherapyAIDS Research and Human Retroviruses, 2009
- Natural Polymorphisms of Human Immunodeficiency Virus Type 1 Integrase and Inherent Susceptibilities to a Panel of Integrase InhibitorsAntimicrobial Agents and Chemotherapy, 2009
- Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006Journal of Antimicrobial Chemotherapy, 2008
- Antiviral Activity, Pharmacokinetics, and Dose Response of the HIV-1 Integrase Inhibitor GS-9137 (JTK-303) in Treatment-Naive and Treatment-Experienced PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Active Generation and Selection for HIV Intersubtype A/D Recombinant Forms in a Coinfected Patient in KenyaAIDS Research and Human Retroviruses, 2004
- HIV-1 Nomenclature ProposalScience, 2000
- Subtypes of Human Immunodeficiency Virus Type 1 and Disease Stage among Women in Nairobi, KenyaJournal of Virology, 1999
- HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transferCell, 1991